VRDN
Viridian Therapeutics Inc
20.50$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +59.5% | -67.0% | +1,132.2% | +26.0% | -54.3% | +333.7% | +55.2% | +113.6% | +12.7% | +51.4% | +21.1% | |
| – | +72.9% | -63.7% | +1,117.8% | +26.0% | -54.5% | +335.8% | +54.4% | +112.1% | +14.6% | +51.8% | +21.1% | |
| – | +111.6% | -69.2% | +1,320.0% | -31.3% | -23.8% | +84.7% | -7.8% | +267.8% | -33.9% | -3.1% | +113.2% | |
| – | +111.6% | -69.2% | +1,320.0% | +31.7% | -57.0% | +375.5% | +54.3% | +115.5% | +12.4% | +50.3% | +21.9% | |
| – | -63.8% | +33.0% | +177.9% | -98.4% | +350.0% | – | – | -77.4% | +0.0% | – | – | |
| – | +4.5% | -65.8% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | -9.9% | +29.1% | -28.1% | +50.5% | -52.4% | +253.6% | – | – | – | |
| – | +18.8% | +84.0% | +204.7% | +6.0% | -2.0% | -22.7% | +42.6% | +150.3% | +20.9% | +46.2% | +150.5% | |
| – | +24.1% | +85.8% | -15.0% | +72.8% | +51.2% | +4.9% | +27.7% | +144.6% | -20.1% | +79.7% | +47.7% | |
| – | +1,281.3% | -5.4% | – | – | +73.3% | -88.6% | +14.3% | +17.9% | +37.5% | -39.1% | +46.8% | |
| – | -5.1% | -34.3% | +469.8% | -37.0% | +91.9% | -38.9% | +247.6% | +511.2% | -84.3% | -4.3% | +305.2% | |
| – | – | – | – | -19.3% | -45.9% | – | – | – | +335.0% | +1.9% | +142.6% | |
| – | +73.8% | -103.1% | – | +33.3% | -69.3% | +661.9% | +56.4% | +110.5% | +11.9% | +51.9% | +7.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +258.7% | +33.7% | +77.8% | +53.8% | +5.9% | +70.3% | +235.1% | +169.2% | +39.5% | +51.7% | +24.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.